Verici Dx plc VRCDF
0.00 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
2.91 Day range 2.91
0.003 52-week range 2.91
- YTD
- 0.00%
- 1 year
- -60.53%
- Market cap
- 19.99M
- EPS (ttm)
- -0.03
- YTD return
- 0.00%
- 1-year return
- -60.53%
- Volume
- 200
- Open
- 2.91
- Previous close
- 0.003
- Day's range
- 2.91 – 2.91
- 52-week range
- 0.003 – 2.91
2Y -0.0270 (-90.00%)
News
Verici Dx plc (VRCDF) Shareholder/Analyst Call Transcript 
Verici Dx gains Olink Certified Service Provider status to expand proteomics offering 
Verici Dx Receives New York State Approval, Establishing Nationwide Access to Tutivia™ Kidney Transplant Rejection Test 
Verici Dx Collaborators to Present Data on Predictive Value of Tutivia™ for Acute Kidney Transplant Rejection at ATC 2026 
CORRECTING and REPLACING Verici Dx Announces Publication Validating Pre-Transplant Gene Signature Test for Predicting Early Acute Rejection in Kidney Transplant Recipients 
Verici Dx Announces Publication Validating Pre-Transplant Gene Signature Test for Predicting Early Acute Rejection in Kidney Transplant Recipients 
Verici Dx rises after passing key US laboratory accreditation audit 
Verici Dx climbs on 'preferred provider' deal with US healthcare network 
Verici Dx plc - Special Call 
Verici Dx shares jump 23% as transplant test rollout gathers pace
Your note
Sign in to keep a note on VRCDF — it syncs with the Stock Master app.